Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.

This week on Tech Byte we travel to the Vascular Institute of Chattanooga for Dr. Will Harris to show us a new tech they have to help treat Peripheral Arterial Disease (PAD) that is new to this end of ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...

STENTiT implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in the VITAL-IT 1 study evaluating the ...

A new statement from leading heart and blood vessel experts in Europe is providing clinical guidance for treatments to ...

WE’RE all aware that chest pain is a common sign that something’s wrong with our heart. But it’s far from the only signal, ...

NRA-Amlodipine 5 mg, DIN 02476460. Issue: Health products - Product safety. What to do: Check your bottle of NRA-Amlodipine 5 mg ...